Share on LinkedInShare on LinkedIn

ARTICLE · 12 NOVEMBER 2020

Patent Strategy In The Life Sciences Industry

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

In this podcast, Finnegan partners John Livingstone and Naoki Yoshida are joined by Rob Gorman, Senior Vice President and Assistant General Counsel for Bausch Health...

United StatesIntellectual Property

In this podcast, Finnegan partners John Livingstone and Naoki Yoshida are joined by Rob Gorman, Senior Vice President and Assistant General Counsel for Bausch Health, to discuss Kaken v. Iancu—the case that led the firm to receive the "Patent Impact Case of the Year" and "Patent Strategy Firm of the Year" awards at the 2020 LMG Life Sciences Awards—and how the case highlights the firm's efforts to align itself with client goals to achieve results. In addition, John and Naoki discuss how Finnegan trains and develops its IP attorneys, and how an IP-driven portfolio must be aligned with business perspectives. The discussion also covers life sciences in the age of coronavirus. 

1005358.jpg

To listen to the podcast, please click here

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from